1. Home
  2. AUPH vs PEB Comparison

AUPH vs PEB Comparison

Compare AUPH & PEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

HOLD

Current Price

$15.34

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Logo Pebblebrook Hotel Trust of Beneficial Interest

PEB

Pebblebrook Hotel Trust of Beneficial Interest

BUY

Current Price

$19.80

Market Cap

1.7B

Sector

Real Estate

ML Signal

BUY

Company Overview

Basic Information
Metric
AUPH
PEB
Founded
1993
2009
Country
Canada
United States
Employees
N/A
52
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
AUPH
PEB
Price
$15.34
$19.80
Analyst Decision
Buy
Hold
Analyst Count
4
11
Target Price
$17.25
$13.30
AVG Volume (30 Days)
2.0M
3.0M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
0.28%
EPS Growth
5075.00
N/A
EPS
0.25
N/A
Revenue
$283,055,000.00
N/A
Revenue This Year
$17.54
N/A
Revenue Next Year
$15.74
$2.25
P/E Ratio
$62.56
N/A
Revenue Growth
20.38
N/A
52 Week Low
$8.80
$9.30
52 Week High
$19.25
$19.78

Technical Indicators

Market Signals
Indicator
AUPH
PEB
Relative Strength Index (RSI) 42.25 68.46
Support Level $14.68 $13.77
Resistance Level $16.38 N/A
Average True Range (ATR) 0.63 0.45
MACD -0.12 0.03
Stochastic Oscillator 11.69 94.10

Price Performance

Historical Comparison
AUPH
PEB

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About PEB Pebblebrook Hotel Trust of Beneficial Interest

Pebblebrook Hotel Trust currently owns upper upscale and luxury hotels with 11,052 rooms across 44 hotels in the United States. Pebblebrook acquired LaSalle Hotel Properties, which owned 10,451 rooms across 41 US hotels, in November 2018, though management has sold many of those hotels over the past few years. Pebblebrook's portfolio consists mostly of independent hotels with no brand affiliations, though the combined company does own and operate some hotels under Marriott, Starwood, InterContinental, Hilton, and Hyatt brands.

Share on Social Networks: